Anti-metastasis efficacy and safety of non-anticoagulant heparin derivative versus low molecular weight heparin in surgical pancreatic cancer models

Publisher： Spandidos Publications

E-ISSN： 1791-2423|46|3|1225-1231

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.46, Iss.3, 2015-01, pp. : 1225-1231

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination therapy with low molecular weight heparin and Adriamycin results in decreased breast cancer cell metastasis in C3H mice

By        

Experimental and Therapeutic Medicine, Vol. 8, Iss. 4, 2014-01 ,pp. : 1213-1218

Spandidos Publications

Access to resources Recommend Favorite

Effects of intensive insulin therapy combined with low molecular weight heparin anticoagulant therapy on severe pancreatitis

By                    

Experimental and Therapeutic Medicine, Vol. 8, Iss. 1, 2014-01 ,pp. : 141-146

Spandidos Publications

Access to resources Recommend Favorite

Cost-minimization analysis of low-molecular-weight heparin (dalteparin) compared to unfractionated heparin for inpatient treatment of cancer patients with deep venous thrombosis

By Avritscher Elenir  

Supportive Care in Cancer, Vol. 12, Iss. 7, 2004-07 ,pp. : 531-536

Springer Publishing Company

Access to resources Recommend Favorite

Low molecular weight heparin suppresses tissue factor-mediated cancer cell invasion and migration in vitro

By            

Experimental and Therapeutic Medicine, Vol. 2, Iss. 2, 2011-01 ,pp. : 363-367

Spandidos Publications

Access to resources Recommend Favorite

The Effect of Low Molecular Weight Heparin Thromboprophylaxis on Bleeding Complications After Gastric Cancer Surgery

By Jeong Oh  

Annals of Surgical Oncology, Vol. 17, Iss. 9, 2010-09 ,pp. : 2363-2369

Springer Publishing Company

Access to resources Recommend Favorite